Niagen Bioscience Inc

NASDAQ:NAGE

Biotechnology

Healthcare
$1.94 +3.31%

+$0.11 today

Market cap
$153.64M
Beta
2.06
P/E (TTM)
14.9
EPS (TTM)
$0.23
52W Low $3.35High $14.69

Volume 0.52M

Average 0.86M

Balance Sheet

Inspect the capital base behind the business.

Assets

$106.41M

FY 2025 · Annual

+55.8% YoY

Liabilities

$29.87M

FY 2025 · Annual

+34.7% YoY

Equity

$76.53M

FY 2025 · Annual

+66.0% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents28.02M20.29M27.17M44.51M64.79M
Short-term Investments00000
Net Receivables5.23M8.48M5.23M7.77M9.74M
Inventory13.6M14.68M14.53M9.19M20.42M
Other Current Assets200K3.12M2.6M2.63M1.85M
Total Current Assets48.91M46.57M49.53M64.1M96.81M
Property, Plant & Equipment (Net)7.36M6.32M4.54M3.45M3.52M
Goodwill00000
Intangible Assets857K671K510K359K5.66M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets723K497K383K368K425K
Total Non-current Assets8.94M7.49M5.43M4.18M9.6M
Total Assets57.84M54.06M54.96M68.28M106.41M
Account Payables10.42M9.68M10.23M8.53M10.8M
Short-term Debt00001M
Tax Payables00000
Deferred Revenue161K157K195K611K0
Other Current Liabilities00008.12M
Total Current Liabilities17.61M17.87M20.62M17.95M19.92M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)4.35M3.96M3.31M2.58M2.67M
Other Non-current Liabilities00005.47M
Total Non-current Liabilities8.5M7.52M5.89M4.24M9.95M
Total Liabilities26.11M25.39M26.51M22.18M29.87M
Common Stock68K74K75K77K79K
Retained Earnings(168.95M)(185.49M)(190.46M)(181.91M)(164.53M)
Accumulated OCI(2K)(3K)(4K)(4K)(9K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity31.73M28.67M28.46M46.09M76.53M
Total Debt4.7M4.26M3.28M2.65M2.82M
Net Debt(23.32M)(16.03M)(23.9M)(41.86M)(61.97M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$66.5M
Receivables$13.1M
Inventory$24.0M
Other Current$1.5M
Total Current Assets$105.1M
PP&E (Net)$3.3M
Intangible Assets$5.5M
Other Non-current$406.0K
Total Non-current Assets$9.2M
Total Assets$114.3M

Analysis

Selected assets total $114.3M for Latest. The largest visible component is Cash & Equivalents at $66.5M, about 58.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026

How much cash does NAGE have?

Niagen Bioscience Inc (NAGE) reported $64.79M in cash and equivalents in fiscal 2025.

How much debt does NAGE carry?

Niagen Bioscience Inc (NAGE) reported $2.82M of total debt, with net debt of -$61.97M.